Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Use of an on-line pager system to increase adherence to antiretroviral medications.

Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH.

AIDS Care. 2003 Dec;15(6):787-93.

PMID:
14617500
2.

A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.

Andrade AS, McGruder HF, Wu AW, Celano SA, Skolasky RL Jr, Selnes OA, Huang IC, McArthur JC.

Clin Infect Dis. 2005 Sep 15;41(6):875-82. Epub 2005 Aug 5.

PMID:
16107989
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
5.

Adherence device developed.

[No authors listed]

AIDS Patient Care STDS. 2001 May;15(5):290. No abstract available.

PMID:
11530772
6.

Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring.

Safren SA, Otto MW, Worth JL, Salomon E, Johnson W, Mayer K, Boswell S.

Behav Res Ther. 2001 Oct;39(10):1151-62.

PMID:
11579986
7.

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.

Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J.

Eur J Clin Pharmacol. 2007 Dec;63(12):1115-21. Epub 2007 Sep 20.

8.
9.
10.

Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study.

Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK; HERS STUDY.

J Acquir Immune Defic Syndr. 2001 Oct 1;28(2):124-31.

PMID:
11588505
11.

Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up.

Nilsson Schönnesson L, Diamond PM, Ross MW, Williams M, Bratt G.

AIDS Care. 2006 May;18(4):407-14.

PMID:
16809121
12.

Baseline predictors of three types of antiretroviral therapy (ART) adherence: a 2-year follow-up.

Nilsson Schönnesson L, Diamond PM, Ross MW, Williams M, Bratt G.

AIDS Care. 2006 Apr;18(3):246-53. Erratum in: AIDS Care. 2006 May;18(4):406. Corrected and republished in: AIDS Care. 2006 May;18(4):407-14.

PMID:
16546786
14.

A two-way messaging system to enhance antiretroviral adherence.

Dunbar PJ, Madigan D, Grohskopf LA, Revere D, Woodward J, Minstrell J, Frick PA, Simoni JM, Hooton TM.

J Am Med Inform Assoc. 2003 Jan-Feb;10(1):11-5.

15.

Measuring HIV treatment adherence in clinical practice.

Hecht FM.

AIDS Clin Care. 1998 Aug;10(8):57-9.

PMID:
11365682
16.

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.

DeMasi RA, Graham NM, Tolson JM, Pham SV, Capuano GA, Fisher RL, Shaefer MS, Pakes GE, Sawyerr GA, Eron JJ Jr.

Adv Ther. 2001 Jul-Aug;18(4):163-73.

PMID:
11697019
17.

Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.

Wohl DA, Stephenson BL, Golin CE, Kiziah CN, Rosen D, Ngo B, Liu H, Kaplan AH.

Clin Infect Dis. 2003 Jun 15;36(12):1572-6. Epub 2003 Jun 6.

PMID:
12802758
18.

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.

Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, Spector SA, Chadwick EG.

Pediatrics. 2000 Jun;105(6):E80.

PMID:
10835093
19.

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, Morse EV, Krogstad PA, Nachman S; Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team.

Pediatrics. 2002 Apr;109(4):e61.

PMID:
11927734
20.

Supplemental Content

Support Center